BioSpace News Archive

Business

IP Veteran Andrew Filler Joins BioSig Technologies’ Board of Directors

Mr. Filler brings to BioSig over 20 years of experience in intellectual property for technology and medical device companies.

November 10, 2017

·

4 min read

Business

Signet Accel Announces Curt Weber as National Sales Director of Pharma Division

With more than two decades in healthcare, Weber will expand Signet Accel’s portfolio of national and international biopharma clients and support the executive team in further establishing the brand as a leader in healthcare technology and data integration.

November 10, 2017

·

3 min read

BioCapital

India Globalization Capital Regains NYSE American Listing Compliance

The Company’s continued listing eligibility will continue to be assessed on an ongoing basis.

November 10, 2017

·

1 min read

Business

PSI and Cluequest Partner to Create The Ultimate Assessment Centre Experience Targeted at Today’s Changing World of Work

PSI today announces a key strategic partnership with clueQuest to provide bespoke immersive escape room assessments for employee selection as an option for employers looking to assess for the changing world of work.

November 10, 2017

·

3 min read

Business

Codexis Reports Financial Results for the Third Quarter of 2017

Total revenues for the third quarter of 2017 were $10.0 million compared with $14.9 million for the third quarter of 2016.

November 10, 2017

·

16 min read

BioMidwest

Alpha Source Recognized for Outstanding Corporate Growth

Alpha Source announced today it was the recipient of the Outstanding Corporate Growth Award, presented by the Wisconsin Chapter of the Association for Corporate Growth.

November 10, 2017

·

2 min read

Drug Development

Celgene’s Ozanimod Successful in Clinical Trials for Multiple Sclerosis

Celgene recently announced results from two phase III trials evaluating the efficacy and safety of the drug ozanimod.

November 10, 2017

·

4 min read

Drug Development

Arena Completes Full Enrollment in Etrasimod Phase II Clinical Study for Ulcerative Colitis

Arena today announced that it has completed full enrollment in the etrasimod Phase 2 study in ulcerative colitis.

November 10, 2017

·

7 min read

Business

Galena Biopharma Reports Third Quarter 2017 Financial Results

Operating loss from Galena’s development programs and general and administrative expenses, classified as continuing operations, during the third quarter of 2017 was $4.5 million.

November 10, 2017

·

13 min read

Business

PLx Pharma Reports Third Quarter 2017 Results

Net loss totaled $3.8 million, or ($0.44) per basic and diluted share, compared to net loss of $1.1 million, or ($0.25) per basic and diluted share, for the third quarter of 2016.

November 10, 2017

·

10 min read